Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
5, Nov 1998, pp
In this context, our data must be viewed as exploratory and hypotheses-generating in nature, and presented for the purpose of providing suggestions for future, more targeted investigations of the myocardial biology of GLP-1 agonism
Leone-Bay A, Grant M, Greene S, Stowell G, Daniels S, Smithson A, et al
US$ 24.86
US$ 28.80
US$ 27.08
US$ 20.20
